World Of Taxonomy
17772-132Level 3

QELBREE (viloxazine hydrochloride)

**Product type:** Human Prescription Drug

**Active ingredient:** VILOXAZINE HYDROCHLORIDE

**Strength:** 150 mg/1

**Dosage form:** Capsule, Extended Release

**Route:** Oral

**Labeler:** Supernus Pharmaceuticals, Inc

**Marketing category:** NDA (NDA211964)

**Pharmacologic class:** Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2B6 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]

GET/api/v1/systems/ndc_fda/nodes/17772-132
Official DownloadPublic Domain (US Government)Source

Hierarchy Explorer

Loading...

Cross-system equivalences0

No cross-system equivalences mapped for this node.